• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effect of cytokine-induced killer cells combined with dendritic cells on the survival rate and expression of 14-3-3ζ and p-Bad proteins in Lewis lung cancer cell lines.细胞因子诱导的杀伤细胞联合树突状细胞对Lewis肺癌细胞系存活率及14-3-3ζ和p-Bad蛋白表达的影响
Oncol Lett. 2018 Aug;16(2):1815-1820. doi: 10.3892/ol.2018.8834. Epub 2018 May 30.
2
[Killing activity of co-cultured cytokine-induced killer cells and dendritic cells against multi-drug resistant tumor cell lines].[共培养的细胞因子诱导杀伤细胞和树突状细胞对多药耐药肿瘤细胞系的杀伤活性]
Zhonghua Zhong Liu Za Zhi. 2007 Oct;29(10):733-7.
3
[Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo].共培养树突状细胞和细胞因子诱导的杀伤细胞对肺癌的体内外抗肿瘤作用
Ai Zheng. 2006 Nov;25(11):1329-33.
4
[Tumor antigen-loaded dendritic cells combined with cytokine-induced killer (CIK) enhance the killing activity of human esophageal cancer cells by promoting ASK1 activation].肿瘤抗原负载的树突状细胞联合细胞因子诱导的杀伤细胞(CIK)通过促进ASK1激活增强人食管癌细胞的杀伤活性
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2023 Jun;39(6):501-508.
5
[The anti-tumor effects of dendritic cells co-cultured with cytokine induced killer cells after chemotherapy].化疗后细胞因子诱导的杀伤细胞与树突状细胞共培养的抗肿瘤作用
Zhonghua Jie He He Hu Xi Za Zhi. 2004 May;27(5):315-9.
6
[Effect of Achyranthes bidentata polysaccharides stimulated dendritic cells co-cultured with cytokine induced killer cells against SW480 cells].牛膝多糖刺激树突状细胞与细胞因子诱导的杀伤细胞共培养对SW480细胞的作用
Zhongguo Zhong Yao Za Zhi. 2013 Apr;38(7):1056-60.
7
Influence of dendritic cells on biological activity of the homologous CIK cells and its anti-leukemia effect in vitro.树突状细胞对同源CIK细胞生物学活性的影响及其体外抗白血病作用
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):946-51.
8
Biological activity of cytotoxic dendritic cells cocultured with cytokine-induced killer cells and their effect on acute leukemia cells.与细胞因子诱导的杀伤细胞共培养的细胞毒性树突状细胞的生物学活性及其对急性白血病细胞的影响。
Genet Mol Res. 2015 Oct 27;14(4):13208-14. doi: 10.4238/2015.October.26.17.
9
Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK.自体细胞因子诱导杀伤细胞(CIK)、树突状细胞-CIK(DC-CIK)和半同种异体DC-CIK抗肿瘤免疫反应的比较研究
Chin J Cancer. 2010 Jul;29(7):641-8. doi: 10.5732/cjc.009.10772.
10
Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.化疗联合细胞因子诱导的杀伤细胞/树突状细胞-细胞因子诱导的杀伤细胞疗法在中国治疗胃癌的有效性和安全性:一项系统评价和荟萃分析。
Cytotherapy. 2016 Sep;18(9):1162-77. doi: 10.1016/j.jcyt.2016.05.015. Epub 2016 Jul 12.

引用本文的文献

1
Tumor-infiltrating lymphocytes in NSCLC: from immune surveillance to immunotherapy.非小细胞肺癌中的肿瘤浸润淋巴细胞:从免疫监视到免疫治疗
Front Immunol. 2025 Jul 25;16:1610998. doi: 10.3389/fimmu.2025.1610998. eCollection 2025.

本文引用的文献

1
A clinical study evaluating dendritic and cytokine-induced killer cells combined with concurrent radiochemotherapy for stage IIIB non-small cell lung cancer.一项评估树突状细胞和细胞因子诱导的杀伤细胞联合同步放化疗治疗IIIB期非小细胞肺癌的临床研究。
Genet Mol Res. 2015 Aug 28;14(3):10228-35. doi: 10.4238/2015.August.28.6.
2
Cytokine-induced killer cells combined with dendritic cells inhibited liver cancer cells.细胞因子诱导的杀伤细胞联合树突状细胞抑制肝癌细胞。
Int J Clin Exp Med. 2015 Apr 15;8(4):5601-10. eCollection 2015.
3
Cytokine-induced killer cells co-cultured with dendritic cells loaded with the protein lysate produced by radiofrequency ablation induce a specific antitumor response.与负载经射频消融产生的蛋白质裂解物的树突状细胞共培养的细胞因子诱导的杀伤细胞可诱导特异性抗肿瘤反应。
Oncol Lett. 2015 Apr;9(4):1549-1556. doi: 10.3892/ol.2015.2977. Epub 2015 Feb 17.
4
Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer.树突状细胞免疫疗法联合细胞因子诱导的杀伤细胞可促进转移性非小细胞肺癌患者向Th2细胞因子谱偏移。
Int Immunopharmacol. 2015 Apr;25(2):450-6. doi: 10.1016/j.intimp.2015.02.010. Epub 2015 Feb 16.
5
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
6
Remarkable regression of a lung recurrence from an undifferentiated embryonal sarcoma of the liver treated with a DC vaccine combined with immune cells: a case report.采用树突状细胞疫苗联合免疫细胞治疗肝脏未分化胚胎性肉瘤后肺转移灶显著消退:一例报告
Cell Immunol. 2014 Aug;290(2):185-9. doi: 10.1016/j.cellimm.2014.05.014. Epub 2014 Jun 18.
7
Effects of a gemcitabine plus platinum regimen combined with a dendritic cell-cytokine induced killer immunotherapy on recurrence and survival rate of non-small cell lung cancer patients.吉西他滨加铂类方案联合树突状细胞-细胞因子诱导的杀伤细胞免疫疗法对非小细胞肺癌患者复发率和生存率的影响
Exp Ther Med. 2014 May;7(5):1403-1407. doi: 10.3892/etm.2014.1574. Epub 2014 Feb 21.
8
Immunotherapy in the treatment of non-small cell lung cancer.免疫疗法在非小细胞肺癌治疗中的应用
Lung Cancer. 2014 Aug;85(2):101-9. doi: 10.1016/j.lungcan.2014.05.005. Epub 2014 May 14.
9
Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients.癌症患者中树突状细胞疫苗联合细胞因子诱导的杀伤细胞疗法的免疫反应、临床结果及安全性
Oncol Lett. 2013 Aug;6(2):537-541. doi: 10.3892/ol.2013.1376. Epub 2013 Jun 4.
10
Astaxanthin inhibits NF-κB and Wnt/β-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer.虾青素通过使Erk/MAPK和PI3K/Akt失活来抑制NF-κB和Wnt/β-连环蛋白信号通路,从而在仓鼠口腔癌模型中诱导内源性凋亡。
Biochim Biophys Acta. 2013 Oct;1830(10):4433-44. doi: 10.1016/j.bbagen.2013.05.032. Epub 2013 May 29.

细胞因子诱导的杀伤细胞联合树突状细胞对Lewis肺癌细胞系存活率及14-3-3ζ和p-Bad蛋白表达的影响

Effect of cytokine-induced killer cells combined with dendritic cells on the survival rate and expression of 14-3-3ζ and p-Bad proteins in Lewis lung cancer cell lines.

作者信息

Hou Yang, Zang Dongyu, Li Xiaoming, Li Fuzhi

机构信息

Life Science Institute of Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China.

Department of Thoraxes Surgery of The Third Affiliated Hospital, Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China.

出版信息

Oncol Lett. 2018 Aug;16(2):1815-1820. doi: 10.3892/ol.2018.8834. Epub 2018 May 30.

DOI:10.3892/ol.2018.8834
PMID:30008870
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6036427/
Abstract

In the present study, the function and mechanism of cytokine-induced killer cells (CIK) combined with dendritic cells (DC-CIK) were examined in Lewis lung cancer (LLC) cells. Co-culture of CIK dendritic cells (DC) was used to investigate their proliferation and the antitumor effects on LLC cells. DC and CIK cells were collected from healthy human peripheral blood mononuclear cells and co-cultured as an experimental group, while LLC cells were cultured alone as a control group. Cell morphology was observed by an inverted microscope and an MTT assay was utilized to detect the proliferation of LLC cells. Expression of 14-3-3ζ and p-Bad were measured by western blot analysis. Compared with the control group, treatment of LLC cells with DC-CIK resulted in decreased cell adherence, reduced cell proliferation and abnormal morphological changes. Additionally, DC-CIK treatment of LLC cells resulted in the decreased expression of 14-3-3ζ and p-Bad protein in LLC cells, which may provide important information pertaining to the possible mechanism of DC-CIK-induced antitumor activity against LLC cells. The present study provides a theoretical and experimental basis for the clinical treatment of DC-CIK cell co-culture.

摘要

在本研究中,检测了细胞因子诱导的杀伤细胞(CIK)联合树突状细胞(DC-CIK)在Lewis肺癌(LLC)细胞中的功能及机制。采用CIK树突状细胞(DC)共培养来研究其增殖情况以及对LLC细胞的抗肿瘤作用。从健康人外周血单个核细胞中收集DC和CIK细胞并作为实验组进行共培养,而LLC细胞单独培养作为对照组。通过倒置显微镜观察细胞形态,并利用MTT法检测LLC细胞的增殖情况。采用蛋白质免疫印迹分析检测14-3-3ζ和p-Bad的表达。与对照组相比,用DC-CIK处理LLC细胞导致细胞黏附减少、细胞增殖降低以及形态异常改变。此外,用DC-CIK处理LLC细胞导致LLC细胞中14-3-3ζ和p-Bad蛋白表达降低,这可能为DC-CIK诱导对LLC细胞的抗肿瘤活性的可能机制提供重要信息。本研究为DC-CIK细胞共培养的临床治疗提供了理论和实验依据。